Articles From: INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of ESB Financial Corp. of Investigation of the Board of Directors of the Company Regarding the Fairness of the Sale of the Company to WesBanco Inc. to Alder BioPharmaceuticals Initiates Phase 2b Clinical Trial of ALD403 for Preventative Treatment of Chronic Migraine


2014/11/3
Levi & Korsinsky is investigating the Board of Directors of ESB Financial Corp.
Sign-up for INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of ESB Financial Corp. of Investigation of the Board of Directors of the Company Regarding the Fairness of the Sale of the Company to WesBanco Inc. investment picks
INCLINE VILLAGE, Nev.
Sign-up for PDL BioPharma to Announce Third Quarter 2014 Financial Results on November 10, 2014 investment picks
SAN DIEGO, Nov.
Sign-up for Receptos to Present at Nomura BioPharma Conference investment picks
2014/11/3
PHILADELPHIA , Nov.
Sign-up for Aberdeen Asia-Pacific Income Fund, Inc. Announces Performance Data And Portfolio Composition investment picks
Global visual technology company RealD Inc. (NYSE: RLD) today announced financial results for its second quarter of fiscal 2015 ended September 30, 2014.
Sign-up for RealD Inc. Reports Second Quarter Fiscal Year 2015 Financial Results investment picks
No Immediate Effect on Listing --
Sign-up for Fuwei Films Announces Receipt of NASDAQ Notice of Deficiency investment picks
2014/11/3
PHILADELPHIA , Nov.
Sign-up for Aberdeen Chile Fund, Inc. Announces Performance Data And Portfolio Composition investment picks
PHILADELPHIA , Nov.
Sign-up for Aberdeen Singapore Fund, Inc.(1) Announces Performance Data and Portfolio Composition investment picks
TARRYTOWN, N.Y. , Nov.
Sign-up for Regeneron Announces Upcoming 2014 Investor Conference Presentations investment picks
STAMFORD, Conn.
Sign-up for Dorian LPG Announces Robert Bugbee Stepping Down from Board investment picks
Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced the closing of its previously announced private offering of $200 million aggregate principal amount of 7.50% Convertible Senior Notes due 2019 (including the full exercise of the over-allotment option granted to the initial purchasers to purchase an additional $25 million aggregate principal amount of 7.50% Convertible Senior Notes due 2019). The notes are unsecured, senior obligations of Synergy and bear interest at a rate of 7.50% per year, payable semiannually in arrears on May 1 and November 1 of each year, beginning on May 1, 2015.
Sign-up for Synergy Pharmaceuticals Inc. Announces Issuance of $200 Million of 7.50% Convertible Senior Notes investment picks
National CineMedia, Inc. (NASDAQ: NCMI) (the Company), the managing member and owner of 45.8% of National CineMedia, LLC (NCM LLC), the operator of the largest in-theatre digital media network in North America, today announced consolidated results for the fiscal third quarter ended September 25, 2014.
Sign-up for National CineMedia, Inc. Reports Results for Fiscal Third Quarter 2014 investment picks
http://media.marketwire.com/attachments/201005/597775_newlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1155942&ProfileId=051205&sourceType=1 SAN JOSE, CA --
Sign-up for Micrel to Present at the Wells Fargo Securities 2014 Technology, Media & Telecom Conference investment picks
2014/11/3
PHILADELPHIA , Nov.
Sign-up for Aberdeen Latin America Equity Fund, Inc. Announces Performance Data And Portfolio Composition investment picks
Hudson Pacific Properties, Inc. (the “Company,” “we,” “us” or “our”) (NYSE: HPP) today announced financial results for the third quarter ended September 30, 2014.
Sign-up for Hudson Pacific Properties, Inc. Announces Third Quarter 2014 Financial Results investment picks
REDWOOD CITY, Calif., Nov.
Sign-up for Codexis Appoints Pam P. Cheng, Merck Global Executive, to Board of Directors investment picks
WellPoint, Inc. (NYSE: WLP) announced today that senior management is scheduled to present at the 2014 Credit Suisse Healthcare Conference on November 11, 2014 at 8:30 a.m. Mountain Standard Time (10:30 a.m. Eastern Standard Time). All interested parties are invited to listen to webcasts of the presentations by visiting www.wellpoint.com and selecting the “Investors” link.
Sign-up for WellPoint Announces Appearance at Upcoming Conference investment picks
2014/11/3
PHILADELPHIA , Nov.
Sign-up for Aberdeen Israel Fund, Inc. Announces Performance Data And Portfolio Composition investment picks
BOSTON , Nov.
Sign-up for Eaton Vance Senior Floating-Rate Trust Report Of Earnings investment picks
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of purchasers of Blue Earth, Inc. (“Blue Earth” or the “Company”) (NASDAQ: BBLU) common stock during the period between October 7, 2013 and October 21, 2014, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until December 23, 2014 to seek appointment as lead plaintiff.
Sign-up for SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Blue Earth, Inc. To Contact Brower Piven Before The December 23, 2014 Lead Plaintiff Deadline In Class Action Lawsuit investment picks
Katanga Mining announces third quarter 2014 production results and date for release of Q3 2014 financial results Canada NewsWire ZUG, Switzerland , Nov.
Sign-up for Katanga Mining announces third quarter 2014 production results and date for release of Q3 2014 financial results investment picks
Interactive Intelligence Group Inc. (Nasdaq: ININ), a global provider of software and services designed to improve the customer experience, has announced financial results for the three and nine months ended Sept.
Sign-up for Interactive Intelligence Reports 2014 Third-Quarter and Nine Months Ended Financial Results investment picks
SHELTON, Conn., Nov.
Sign-up for Cara Therapeutics to Announce Third Quarter 2014 Financial Results on November 10, 2014 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of ESB Financial Corp. of Investigation of the Board of Directors of the Company Regarding the Fairness of the Sale of the Company to WesBanco Inc. to Alder BioPharmaceuticals Initiates Phase 2b Clinical Trial of ALD403 for Preventative Treatment of Chronic Migraine
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent